Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
- 16 February 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (9) , 4281-4286
- https://doi.org/10.1073/pnas.1000621107
Abstract
To improve the efficacy of T cell-based vaccination, we pursued the principle that CD4(+) T cells provide help for functional CD8(+) T cell immunity. To do so, we administered HIV gag to mice successively as protein and DNA vaccines. To achieve strong CD4(+) T cell immunity, the protein vaccine was targeted selectively to DEC-205, a receptor for antigen presentation on dendritic cells. This targeting helped CD8(+) T cell immunity develop to a subsequent DNA vaccine and improved protection to intranasal challenge with recombinant vaccinia gag virus, including more rapid accumulation of CD8(+) T cells in the lung. The helper effect of dendritic cell-targeted protein vaccine was mimicked by immunization with specific MHC II binding HIV gag peptides but not peptides from a disparate Yersinia pestis microbe. CD4(+) helper cells upon adoptive transfer allowed wild-type, but not CD40(-/-), recipient mice to respond better to the DNA vaccine. The transfer also enabled recipients to more rapidly accumulate gag-specific CD8(+) T cells in the lung following challenge with vaccinia gag virus. Thus, complementary prime boost vaccination, in which prime and boost favor distinct types of T cell immunity, improves plasmid DNA immunization, including mobilization of CD8(+) T cells to sites of infection.Keywords
This publication has 33 references indexed in Scilit:
- CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell helpNature, 2009
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysNature, 2008
- ‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 LigandsPLOS ONE, 2008
- Macaques vaccinated with live-attenuated SIV control replication of heterologous virusThe Journal of Experimental Medicine, 2008
- The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cellsJournal of Clinical Investigation, 2008
- The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccineProceedings of the National Academy of Sciences, 2008
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responsesThe Journal of Experimental Medicine, 2008
- Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cellsEuropean Journal of Immunology, 2007
- Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three CytokinesJournal of Virology, 2007
- Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virusThe Journal of Experimental Medicine, 2007